Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis.

Sadnicka, Anna

Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis. [electronic resource] - Journal of neurology, neurosurgery, and psychiatry Feb 2011 - 230-2 p. digital

Publication Type: Case Reports; Journal Article

1468-330X

10.1136/jnnp.2009.174888 doi


Aged
Anti-Inflammatory Agents--therapeutic use
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Antineoplastic Agents--therapeutic use
Autoimmune Diseases--drug therapy
Electroencephalography
Electromyography
Humans
Immunoglobulins, Intravenous--therapeutic use
Magnetic Resonance Imaging
Male
Methylprednisolone--therapeutic use
Myasthenia Gravis--drug therapy
Neural Conduction--physiology
Neurologic Examination
Plasma Exchange
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating--drug therapy
Rituximab
Syringomyelia--drug therapy
Tomography, X-Ray Computed